Education
About Us
Working with TipRanks
Follow Us
SMRI - ETF AI Analysis
Top Page
Bushido Capital US Equity ETF (SMRI)
Rating:73Outperform
Price Target:―
Positive Factors
Strong Top Holdings Performance
Most of the largest positions have shown strong gains this year, which has helped support the fund despite recent weakness.
Broad Sector Diversification
The ETF spreads its investments across several sectors, including technology, health care, energy, and consumer-related industries, which helps reduce reliance on any single area of the market.
Meaningful Fund Size
With several hundred million dollars in assets, the fund is large enough to offer stability and efficient trading for most individual investors.
Negative Factors
Relatively High Expense Ratio
The fund charges a higher fee than many broad U.S. equity ETFs, which can gradually reduce investors’ net returns over time.
Recent Performance Softness
The ETF has shown weak results over the past month and slightly negative performance so far this year, which may concern investors looking for steady gains.
Heavy U.S.-Only Exposure
Almost all of the fund’s holdings are in U.S. companies, offering little geographic diversification if the U.S. market struggles.
SMRI vs. SPDR S&P 500 ETF (SPY)
AUM508.69M
RegionNorth America
Expense Ratio0.71%
Beta0.83
IssuerBushido
Inception DateSep 14, 2023
Dividend Yield1.31%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume11,177
30 Day Avg. Volume10,964
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
41.93Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering51
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SMRI Summary
The Bushido Capital US Equity ETF (SMRI) is an actively managed fund that invests in a wide range of U.S. companies, with a focus on finding stocks that appear undervalued but have room to grow. It does not track a specific index, but follows a value-investing theme across the total U.S. stock market. The fund holds well-known names like Chevron and Schlumberger, and spreads money across sectors such as technology, health care, and energy. Someone might invest for long-term growth and diversification within U.S. stocks. A key risk is that its stock prices can go up and down with the overall market.
How much will it cost me?The Bushido Capital US Equity ETF (Ticker: SMRI) has an expense ratio of 0.72%, meaning you’ll pay $7.20 per year for every $1,000 invested. This is higher than average because it is actively managed, which typically involves more research and decision-making compared to passively managed funds that track an index.
What would affect this ETF?The Bushido Capital US Equity ETF (SMRI) could benefit from growth in the technology and healthcare sectors, which make up a significant portion of its holdings, especially if innovation and demand in these areas continue to rise. However, potential risks include economic downturns or rising interest rates, which could negatively impact value stocks and sectors like energy and consumer cyclical. Regulatory changes or geopolitical tensions affecting U.S. markets may also influence the ETF's performance.
SMRI Top 10 Holdings
SMRI is leaning into classic value themes, with energy names like Schlumberger and Valero helping power recent gains, while Chevron and Marathon Petroleum look a bit more mixed, adding some volatility to the ride. Industrial player Mueller Industries has been quietly rising, giving the fund a steady backbone, and homebuilders such as PulteGroup and Toll Brothers are contributing a slow but constructive climb. With all holdings based in the U.S. and notable tilts toward energy, industrials, and housing, this ETF feels like a focused bet on the real economy rather than flashy growth stories.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Tenet Healthcare | 2.44% | $12.35M | $20.59B | 70.84% | 74 Outperform | |
| Devon Energy | 2.35% | $11.88M | $27.12B | 18.28% | 79 Outperform | |
| NRG Energy | 2.33% | $11.81M | $33.24B | 52.18% | 69 Neutral | |
| Coterra Energy | 2.33% | $11.78M | $23.57B | 9.69% | 73 Outperform | |
| Carlisle Companies | 2.31% | $11.69M | $16.68B | 15.68% | 70 Outperform | |
| Royalty Pharma | 2.31% | $11.69M | $26.20B | 37.56% | 79 Outperform | |
| Renaissancere Holdings | 2.26% | $11.44M | $13.36B | 32.04% | 78 Outperform | |
| Toll Brothers | 2.25% | $11.38M | $15.52B | 39.28% | 77 Outperform | |
| Marathon Petroleum | 2.24% | $11.33M | $60.28B | 27.41% | 66 Neutral | |
| PulteGroup | 2.23% | $11.26M | $27.20B | 35.51% | 70 Outperform |
SMRI Technical Analysis
Positive
―
Price Trends
36.40
Negative
35.59
Positive
34.03
Positive
Market Momentum
-0.05
Negative
51.81
Neutral
80.33
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SMRI, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 36.22, equal to the 50-day MA of 36.40, and equal to the 200-day MA of 34.03, indicating a neutral trend. The MACD of -0.05 indicates Negative momentum. The RSI at 51.81 is Neutral, neither overbought nor oversold. The STOCH value of 80.33 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SMRI.
SMRI Peer Comparison
Comparison Results
Performance Comparison
SMRI
Bushido Capital US Equity ETF
36.39
3.95
12.18%
SYLD
Cambria Shareholder Yield ETF
―
―
―
PLDR
Putnam Sustainable Leaders ETF
―
―
―
ABFL
Fcf Us Quality Etf
―
―
―
BGDV
Bahl & Gaynor Dividend ETF
―
―
―
XCHG
AB US Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents